To determine whether ME2 promotes PMT of glioma cells, we performed a western blot assay to detect the expression of MES markers MET, YKL40, N-cadherin, and vimentin; epithelial marker E-cadherin; and PN marker OLIG2. Here, CDH2 is linked to central nervous system cancer.